Alexander IV

Alexander IV is a biotechnology company focused on the development of advanced nanomedicine and drug delivery systems. Founded by Dr. Alexander Kabanov, a pioneer in the field of polymer-based drug delivery, the company leverages polymeric micelles and block copolymers to enhance the therapeutic efficacy of small molecules and proteins. Its primary research areas include the treatment of neurological disorders, such as Parkinson's disease and stroke, as well as various forms of cancer. The company's platform technology focuses on the delivery of antioxidant enzymes and chemotherapeutic agents across the blood-brain barrier and into tumor tissues. Alexander IV operates primarily as an R&D-focused entity, often collaborating with academic institutions and securing federal research grants to advance its pipeline.